Ufalaza tablets tablets 20 pcs.

• Benign prostatic hyperplasia.
• Dysuric disorders (as part of complex therapy): frequent urge to urinate, difficulty urinating, pain and discomfort in the perineum area, which accompany benign prostatic hyperplasia.

• active ingredients: 1 tablet contains: affinity purified antibodies to endothelial NO synthase: a mixture of homeopathic dilutions C12, C30 and C200 – 6 mg; affinity purified antibodies to prostate-specific antigen: a mixture of homeopathic dilutions C12, C30 and C200 – 6 mg;
• excipients: lactose monohydrate, microcrystalline cellulose, magnesium stearate.

Increased individual sensitivity to the components of the drug.

Lactase deficiency, lactose intolerance, glucose-galactose malabsorption.

It is contraindicated for use in children (under 18 years of age).

Reactions of increased individual sensitivity to the components of the drug are possible.

The drug is taken orally, 2 tablets per dose (do not take with food). Keep the tablet in your mouth (preferably without chewing or swallowing) until completely dissolved. Take the drug twice a day, in the evening and in the morning.

For dysuric disorders, it is recommended to take the drug for 16 weeks.

On the recommendation of a doctor, in case of severe pain syndrome and dysuric disorders, the drug is indicated to be taken up to 4 times a day in the first 2–3 weeks of therapy.

The duration of treatment is determined by the doctor individually.

To prevent prostate growth in patients with benign prostatic hyperplasia (BPH) and reduce the risk of disease progression, the drug is recommended to be taken twice a day, in the evening and in the morning, for 12 months.

The medicinal product contains lactose monohydrate, therefore it should not be prescribed to patients with congenital galactosemia, glucose malabsorption syndrome or congenital lactase deficiency.

If the symptoms of the disease do not decrease or, on the contrary, increase, you should consult a doctor.

Use during pregnancy or breastfeeding

For use in adult males. Do not use in women.

Children

The drug is contraindicated in children (under 18 years of age).

The drug does not affect the ability to drive vehicles and other potentially dangerous mechanisms.

In case of accidental overdose, dyspeptic manifestations caused by the components included in the medicinal product are possible.

No cases of interaction with other drugs have been registered.

Store at a temperature not exceeding 25 °C.

Keep out of reach of children.